Vycor Medical (VYCO) Research & Development (2010 - 2025)
Vycor Medical's (VYCO) quarterly Research & Development came in at $4201.0 in Q2 2025, up 85.64% year-on-year from $2263.0 in Q2 2024, and down 27.09% on a QoQ basis from $5762.0 in Q1 2025.
Vycor Medical (VYCO) Research & Development (2010 - 2025) Analysis & Trends
Vycor Medical (VYCO) has 11 years of Research & Development data on file, last reported at $4201.0 in Q2 2025.
- On a quarterly basis, Research & Development rose 85.64% year-over-year to $4201.0 in Q2 2025; TTM through Dec 2025 was $9963.0, a 43.31% decrease from a year earlier, with the FY2025 full-year figure at $9963.0, down 34.99% from the prior year.
- Research & Development for Q2 2025 stood at $4201.0, down from $5762.0 in the prior quarter.
- Over the last five years, Research & Development for VYCO reached as high as $7550.0 in Q2 2023 and fell as low as $1825.0 in Q3 2021.
- Historically, Research & Development has averaged $4846.5 across 4 years, with a median of $5508.0 in 2023.
- On a YoY basis, Research & Development climbed as much as 194.98% in 2024 and fell as far as 70.03% in 2024.
- Year by year, Research & Development stood at $6705.0 in 2021, then slumped by 66.44% to $2250.0 in 2023, then soared by 194.98% to $6637.0 in 2024, then tumbled by 36.7% to $4201.0 in 2025.
- Per Business Quant data, the three most recent Research & Development figures were $4201.0 in Q2 2025, $5762.0 in Q1 2025, and $6637.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 4,201.00 |
| Mar 31, 2025 | 5,762.00 |
| Dec 31, 2024 | 6,637.00 |
| Sep 30, 2024 | 6,425.00 |
| Jun 30, 2024 | 2,263.00 |
| Dec 31, 2023 | 2,250.00 |
| Sep 30, 2023 | 7,250.00 |
| Jun 30, 2023 | 7,550.00 |
| Mar 31, 2023 | 5,508.00 |
| Dec 31, 2021 | 6,705.00 |
| Sep 30, 2021 | 1,825.00 |
| Jun 30, 2021 | 3,929.00 |
| Mar 31, 2021 | 2,700.00 |
| Dec 31, 2016 | 586.00 |
| Sep 30, 2016 | 4,153.00 |
| Dec 31, 2015 | 3,268.00 |
| Sep 30, 2015 | 29,346.00 |
| Jun 30, 2015 | 15,672.00 |
| Mar 31, 2015 | 23,226.00 |
| Sep 30, 2014 | 6,933.00 |